According to Qiagen 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.56971. At the end of 2023 the company had a P/S ratio of 5.19.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.19 | -2.09% |
2022 | 5.30 | -5.51% |
2021 | 5.61 | -13.18% |
2020 | 6.46 | 28.17% |
2019 | 5.04 | -2.51% |
2018 | 5.17 | 4.73% |
2017 | 4.94 | 0.69% |
2016 | 4.91 | -2.46% |
2015 | 5.03 | 24.25% |
2014 | 4.05 | -5.37% |
2013 | 4.28 | 26.04% |
2012 | 3.39 | 22.77% |
2011 | 2.76 | -34.05% |
2010 | 4.19 | -18.33% |
2009 | 5.13 | 31.91% |
2008 | 3.89 | -38.52% |
2007 | 6.33 | 29.73% |
2006 | 4.88 | 11.41% |
2005 | 4.38 | 3.52% |
2004 | 4.23 | -15.01% |
2003 | 4.98 | 96.74% |
2002 | 2.53 | -74.94% |
2001 | 10.1 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | 4.45 | -2.67% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | 3.97 | -13.02% | ๐บ๐ธ USA |
![]() General Electric GE | 1.78 | -60.96% | ๐บ๐ธ USA |
![]() Hologic HOLX | 4.24 | -7.22% | ๐บ๐ธ USA |
![]() Bio-Techne TECH | 9.40 | 105.69% | ๐บ๐ธ USA |